|
RPS6KA3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.098800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.787600E-01 |
| Normal-vs-Stage2 |
9.009600E-01 |
| Normal-vs-Stage3 |
1.328270E-02 |
| Normal-vs-Stage4 |
1.046310E-02 |
| Stage1-vs-Stage2 |
8.154200E-01 |
| Stage1-vs-Stage3 |
2.992300E-02 |
| Stage1-vs-Stage4 |
1.657740E-02 |
| Stage2-vs-Stage3 |
1.319350E-01 |
| Stage2-vs-Stage4 |
9.810400E-02 |
| Stage3-vs-Stage4 |
7.777200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.150600E-01 |
| Normal-vs-AfricanAmerican |
1.217570E-03 |
| Normal-vs-Asian |
8.154400E-01 |
| Caucasian-vs-AfricanAmerican |
6.500400E-03 |
| Caucasian-vs-Asian |
6.136000E-01 |
| AfricanAmerican-vs-Asian |
9.438000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.379700E-02 |
| Normal-vs-Female |
4.848600E-01 |
| Male-vs-Female |
2.377800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.014250E-01 |
| Normal-vs-Age(41-60Yrs) |
3.537200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.078200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.622030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.620800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.842000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.088200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.849200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.696200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.072800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.949600E-01 |
| Normal-vs-Grade 2 |
6.074400E-01 |
| Normal-vs-Grade 3 |
5.574500E-02 |
| Normal-vs-Grade 4 |
6.782800E-03 |
| Grade 1-vs-Grade 2 |
5.810200E-01 |
| Grade 1-vs-Grade 3 |
1.923610E-01 |
| Grade 1-vs-Grade 4 |
5.976100E-02 |
| Grade 2-vs-Grade 3 |
1.429970E-01 |
| Grade 2-vs-Grade 4 |
1.660220E-02 |
| Grade 3-vs-Grade 4 |
1.760760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.972200E-01 |
| Normal-vs-ccB subtype |
3.830200E-01 |
| ccA subtype-vs-ccB subtype |
3.351000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.452000E-01 |
| Normal-vs-N1 |
3.834800E-01 |
| N0-vs-N1 |
6.524400E-01 |
|
|
